F. Dugay

发表

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2017, Targeted Oncology.

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma

B. Boisselier, P. Menei, P. Guardiola, 2018, Oncotarget.

Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma.

N. Rioux-Leclercq, J. Andrieux, S. Odent, 2013, European journal of medical genetics.

Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression

K. Bensalah, N. Rioux-Leclercq, E. Compérat, 2022, Histopathology.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.

N. Rioux-Leclercq, G. Bouzillé, N. Stock, 2017, Human pathology.

Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.

K. Bensalah, N. Rioux-Leclercq, S. Jaillard, 2019, Human pathology.

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

N. Rioux-Leclercq, S. Terry, C. Sautès-Fridman, 2021, Clinical Cancer Research.

Immunotherapy in Renal Cell Carcinoma: The Future Is Now

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2020, International journal of molecular sciences.

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

A. Lespagnol, A. Gros, J. Merlio, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma

K. Bensalah, N. Rioux-Leclercq, R. Mathieu, 2019, International journal of molecular sciences.

Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases

K. Bensalah, N. Rioux-Leclercq, A. Lespagnol, 2017, Virchows Archiv.

Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2016, European urology focus.

Postnatal diagnosis of 9q interstitial imbalances involving PTCH1, resulting from a familial intrachromosomal insertion.

L. Pasquier, S. Odent, C. Dubourg, 2014, European journal of medical genetics.

Overexpression of the polarity protein PAR‐3 in clear cell renal cell carcinoma is associated with poor prognosis

N. Rioux-Leclerq, X. Goff, C. Vigneau, 2014, International journal of cancer.

Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.

K. Bensalah, N. Rioux-Leclercq, E. Oger, 2013, Human pathology.

Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)

J. Patard, P. Fergelot, J. Delcros, 2013, PloS one.

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients. Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.

N. Rioux-Leclercq, H. Léna, Sarah Medane, 2017, Oncotarget.

Renal cell carcinoma with leiomyomatous stroma in tuberous sclerosis complex: a distinct entity

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2020, Virchows Archiv.

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

V. Quillien, F. Belloc, F. Dugay, 2012, Neuro-oncology.

[Cytogenetics profiles of renal carcinoma].

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2014, Morphologie : bulletin de l'Association des anatomistes.

Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study

K. Bensalah, N. Rioux-Leclercq, A. Lespagnol, 2021, Journal of Clinical Pathology.

Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.

K. Bensalah, N. Rioux-Leclercq, P. Fergelot, 2014, Human pathology.

[Renin-angiotensin system and urological cancers].

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11)

T. Fest, R. Marschalek, C. Bastard, 2014, Leukemia & lymphoma.

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations

N. Rioux-Leclercq, H. Léna, Sarah Medane, 2017, Oncotarget.

Synchronous Metastatic Clear‐Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

K. Bensalah, N. Rioux-Leclercq, J. Mosser, 2017, Clinical genitourinary cancer.

[Renin-angiotensin system and urological cancers].

K. Bensalah, N. Rioux-Leclercq, T. Dolley-Hitze, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.

N. Rioux-Leclercq, G. Bouzillé, N. Stock, 2017, Human pathology.